Mortgage insurers step into the M&A light

Arch Capital’s purchase of UGC underlines industry’s renaissance

Stratasys STRATYSYS 3D printers to 3D production systems, Stratasys machines

Stratasys eyes plane interior 3D printing

Group working on technology to make parts on a much larger scale

China tech fundraising accelerates

Fintech groups in Asia raise $9.6bn in first half

BuzzFeed to split into two divisions

Online media group to keep journalism and entertainment separate

Fitbit: bearable wearable

Legal ruling is a boost but the path ahead will have obstacles

FBI probes cyber attacks on NYT reporters

Russian hackers suspected of hacking media group

Apollo to pay $53m for misleading clients

SEC ramps up scrutiny of fees charged by private equity groups

Fitbit Alta

Fitbit cleared of stealing Jawbone data

Rival’s case had threatened sales of its activity trackers in US

AIG: last men standing

Cost-cutting has kept Carl Icahn at bay

AIG eyes sale of Lloyd’s-connected units

New York-based insurer in talks with Canadian pension fund

Big banks plan new digital currency

Group of major lenders seeks industry standard for settlements

Bank of Montreal shrugs off oil price drop

Lender’s profits rise augurs well for nation’s banking sector

Co-op Bank to hire BofA as adviser

UK lender to bring US bank on board over potential sale

C5 Capital aims to raise $150m cloud fund

Fund manager appoints European head of Intel Capital

The lawyer calling big auditors to account

Steven Thomas’s pursuit of PwC has made him the go-to guy in auditor liability

Sponsors dump US swimmer Ryan Lochte

Speedo and Ralph Lauren cut ties following Rio ‘robbery’ debacle

Apple’s Tim Cook: five years, five charts

CEO has maintained growth but left investors wanting more

Liverpool fans cautious on new investors

Supporters keen for more details about interest from consortium involving state-backed Chinese group

Cook must transcend Jobs’ legacy at Apple

Chief executive has done justice to the co-founder but has more to do

Pfizer looks to conquer cancer with deal

Drugmaker’s $14bn deal is part of strategy to lead in oncology


More FT Twitter accounts